| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003057838A3 Antibodies against the muc18 antigen |
| 03/11/2004 | WO2003046572A3 Biopolymer markers predictive of alzheimers disease |
| 03/11/2004 | WO2003042247A3 Modified anti-tnf alpha antibody |
| 03/11/2004 | WO2003035826A3 Genetic screening methods |
| 03/11/2004 | WO2003025116A3 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production |
| 03/11/2004 | WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/11/2004 | WO2003018771A3 A system for antibody expression and assembly |
| 03/11/2004 | WO2003008548A3 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048373 Production and long-term in vitro culture of these cell populations, and the use of neuroblasts in the treatment of various neuronal disorders as well as the identification of compositions which affect neuroblasts |
| 03/11/2004 | US20040048368 Polypeptide production in animal cell culture |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048347 The oligomers may be provided to ruminants as bioavailable amino acid supplements that are resistant to degradation in the rumen |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048337 Process for producing glutathione |
| 03/11/2004 | US20040048335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048334 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048333 Membrane/fusion proteins; PRO polypeptides; immunoglobulins; solid phase synthesis; for modulating uptake of glucose by skeletal muscle cells |
| 03/11/2004 | US20040048331 For detection of mammalian tumors; for production of Lewis Y antigens; tumor associated antigens; immunoassay; rep genes/proteins; fusion proteins |
| 03/11/2004 | US20040048319 Activated leukocyte cell adhesion molecule (ALCAM); immunoglobulins; membrane proteins; for controlling neovascularization; anticancer agents; immunotherapy |
| 03/11/2004 | US20040048298 An endogenous nucleic acid fragment of the retroviral type, integrated into the DNA of the human genome |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048289 A protein specific to a magnetic particle membrane, DNA which encodes the protein and their uses |
| 03/11/2004 | US20040048288 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 03/11/2004 | US20040048277 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040047954 Analytical method for the determination of infant formula protein digestibility in vitro |
| 03/11/2004 | US20040047881 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
| 03/11/2004 | US20040047880 Component for vaccine |
| 03/11/2004 | US20040047860 Antibodies to human mcp-1 |
| 03/11/2004 | US20040047845 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 03/11/2004 | CA2497047A1 Adzymes and uses thereof |
| 03/11/2004 | CA2496885A1 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | CA2496626A1 Selecting therapeutic human monoclonal antibodies from disease-specific libraries |
| 03/11/2004 | CA2495295A1 Group b streptococcal phage lysin |
| 03/11/2004 | CA2495212A1 Analytical method for the determination of infant formula protein digestibility in vitro |
| 03/11/2004 | CA2494981A1 Production of multimeric fusion proteins using a c4bp scaffold |
| 03/11/2004 | CA2491568A1 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 03/10/2004 | EP1396546A2 mycobacteria functional screening and/or expression vectors |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396541A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
| 03/10/2004 | EP1396539A1 Human-type anti-blood coagulation factor viii antibody |
| 03/10/2004 | EP1396500A1 Anti-trail-r antibodies |
| 03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |
| 03/10/2004 | EP1395669A2 Matrix attachment regions and methods for use thereof |
| 03/10/2004 | EP1395666A1 Protease deficient caulobacter host cells |
| 03/10/2004 | EP1395665A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus |
| 03/10/2004 | EP1395658A2 Nucleic acid and protein sequences of bovine epidermal growth factor |
| 03/10/2004 | EP1395656A2 Human drug metabolizing enzymes |
| 03/10/2004 | EP1395611A2 Methods and compositions for treating respiratory mucin production associated disease conditions |
| 03/10/2004 | EP1395609A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 03/10/2004 | EP1395608A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/10/2004 | EP1395284A2 Cd4-specific antibody trx1 and uses therefor |
| 03/10/2004 | EP1395275A2 Beta-secretase substrates and uses thereof |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/10/2004 | EP0651653B1 p53 VACCINE |
| 03/10/2004 | CN1481439A Method for prodn. of heterologous protein by fungus |
| 03/10/2004 | CN1481438A Method for preparing vitamin K-dependence protein |
| 03/10/2004 | CN1480536A Method for prompting ice nucleus active bacteria to highly express ice nucleus active protein |
| 03/10/2004 | CN1480464A Ethane cyclic amp receptor protein of wheat and its coding sequence |
| 03/10/2004 | CN1141395C Prepn. of metallothionein |
| 03/10/2004 | CN1141394C Production process of active casein polypeptide with coarse cheese |
| 03/10/2004 | CN1141393C Method for catalyzing sequential enzyme reaction by using fusion protein |
| 03/10/2004 | CN1141317C Cyelosporin derivatives with anti-HIV effect |
| 03/09/2004 | US6703490 Amphiphilic complexes, method for their preparation and compositions containing them |
| 03/09/2004 | US6703486 Peripheral nervous system specific sodium channels |
| 03/09/2004 | US6703485 Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 03/09/2004 | US6703484 Generating prferential polypeptides; obtain cells, transform with expression vector, culture cell, recover preferential polypeptides |
| 03/09/2004 | US6703018 Method of treatment using humanized anti-CD11a antibodies |
| 03/04/2004 | WO2004019000A2 Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
| 03/04/2004 | WO2004018997A2 Methods and compositions for modulating amyloid beta |
| 03/04/2004 | WO2004018692A1 Method and device for the biotechnological production of valuable products |
| 03/04/2004 | WO2004018681A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 03/04/2004 | WO2004018672A1 NOVEL ALDOLASES AND PROCESS FOR PRODUCING SUBSTITUTED α-KETO ACID |
| 03/04/2004 | WO2004018670A1 Inhibitor of physiological activity of annexin 5 |
| 03/04/2004 | WO2004018651A1 Novel microorgnaism sensitive to lysozyme |
| 03/04/2004 | WO2004017923A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | WO2004017899A2 Mono-specific polyclonal antibodies and methods for detecting clostridium difficile toxin a |
| 03/04/2004 | WO2004017810A2 Tumor specific oligosaccharide epitopes and use thereof |
| 03/04/2004 | WO2003106674A3 Use of repression blocking sequences in methods for enhancing gene expression |
| 03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
| 03/04/2004 | WO2003097871A8 Marker molecules associated with lung tumors |
| 03/04/2004 | WO2003082206A3 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses |
| 03/04/2004 | WO2003073107A3 Neuropeptide receptor and uses thereof |
| 03/04/2004 | WO2003070760A3 Anti-amyloid beta antibodies and their use |
| 03/04/2004 | WO2003057174A3 Methods and compositions for protein expression and purification |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003050254A3 Novel chimeric tnf ligands |
| 03/04/2004 | WO2003048301A3 Anti-hla-dr antibodies and the methods of using thereof |
| 03/04/2004 | WO2003044054A3 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 03/04/2004 | WO2003019198A3 Methods relating to treatment of atherosclerosis |
| 03/04/2004 | WO2003019196A3 Diagnosis and treatment of atherosclerosis |
| 03/04/2004 | WO2003017924A3 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |